Accelerate Diagnostics Inc.
13F holders, Q1 2024 (March 31)1holders
$0.99avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Accelerate Diagnostics Inc. in their 13F filings. The largest holder was Birchview Capital, LP ($322K).
- Company
- Accelerate Diagnostics Inc.
- CUSIP
- 00430H102
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $270K |
Ownership 1 holders
| Birchview Capital, LP | 0.26% | Add +44.4% | 325,239 | $322K |
"% of holder's portfolio" is ACCELERATE DIAGNOSTICS INC's weight in each manager's 13F, not the share of Accelerate Diagnostics Inc. the manager owns.